Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction - Role of neurohormones and cytokines

International Journal of Cardiology

Volumn 88, Issue 2-3, 2003, Pages 257-265

  Takahashi, Toshiyuki ^a   Anzai, Toshihisa ^a   Yoshikawa, Tsutomu ^a   Maekawa, Yuichiro ^a   Asakura, Yasushi ^a   Satoh, Toru ^a   Mitamura, Hideo ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioplasty; Cytokine; Inflammatory response; Neurohormone; Sympathetic activation

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; NEUROHORMONE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; Q WAVE; SERUM;

EID: 0037398038     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00416-3     Document Type: Article

References (27)

1. White H.D., Norris R.M., Brown M.A., Brandt P.W.T., Whitlock R.M.L., Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 76:1987;44-51.
2. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 81:1990;1161-1172.
3. Zardini P., Marino P., Golia G., Anselmi M., Castelli M. Ventricular remodeling and infarct expansion. Am J Cardiol. 72:1993;98G-106G.
4. Anzai T., Yoshikawa T., Shiraki H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 96:1997;778-784.
5. Pietila K., Harmoinen A., Hermens W., Simoons M.L., Van de Werf F., Verstrete M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J. 14:1993;915-919.
6. Miyao Y., Yasue H., Ogawa H., et al. Elevated plasma interleukin-6 level in patients with acute myocardial infarction. Am Heart J. 126:1993;1299-1304.
7. Ono K., Matsumori A., Shioi T., et al. Cytokine gene expression after myocardial infarction in rat hearts. Circulation. 96:1998;149-156.
8. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 31:1998;391-398.
9. Bürger A., Benicke M., Deten A., et al. Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol. 281:2001;H14-H21.
10. Killip T., Kimball J.T. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol. 20:1967;457-464.
11. Forrester J.S., Diamond G., Chatterjee K., Swan H.J.C. Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med. 295:1976;1356-1362.
12. Shiraki H., Yoshikawa T., Anzai T., et al. Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med. 338:1998;941-947.
13. Rentrop K.P., Cohen M., Blanke H., Phillips R. Changes in collateral channel filling after controlled coronary occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 5:1985;587-592.
14. Meizlish J.L., Berger H.J., Plankey M., Errico D., Levy W., Zaret B.L. Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. N Engl J Med. 311:1984;1001-1006.
15. Beranek J.T. C-reactive protein and complement in myocardial infarction and postinfarction heart failure. Eur Heart J. 18:1997;1834-1835.
16. Lagrand W.K., Niessen H.W.M., Wolbink G.-J., et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation. 95:1997;97-103.
17. Griselli M., Herbert J., Hutchinson W.L., et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med. 190:1999;1733-1739.
18. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 327:1992;669-677.
19. Dostal D.E., Baker K.M. The cardiac renin-angiotensin system. Conceptual, or a regulator of cardiac function? Circ Res. 85:1999;643-650.
20. Benedict C.R., Shelton B., Johnstone D.E., et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation. 94:1996;690-697.
21. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 311:1984;819-823.
22. Huang Q.H., Takaki A., Arimura A. Central noradrenergic system modulates plasma interleukin-6 production by peripheral interleukin-1. Am J Physiol. 273:1997;R731-R738.
23. Barth W., Deten A., Bauer M., Reinohs M., Leicht M., Zimmer H.G. Differential remodeling of the left heart after norepinephrine treatment in rats: studies on cytokines and collagen. J Mol Cell Cardiol. 32:2000;273-284.
24. Anzai T., Yoshikawa T., Takahashi T., et al. Early use of beta-blockers is associated with an attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction [abstract]. J Am Coll Cardiol. 37:(Suppl A):2001;317A.
25. Basu S., Senior R., Raval U., et al. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction: a placebo-controlled, randomized trial. Circulation. 96:1997;183-191.
26. Tsutamoto T., Wada A., Maeda K. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516.
27. Morita E., Yasue H., Yoshimura H., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 88:1993;82-91.